The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...
Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer's disease, ALS and other brain ...
Lilly will add the center to a site in Lebanon, Indiana, where it is already spending about $9 billion to improve ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...
As Eli Lilly has surged to become the most valuable company in biopharma—with a market cap now more than twice that of ...
Eli Lilly & Co. closed $85.37 below its 52-week high ($972.53), which the company reached on August 22nd.
Eli Lilly and Company announced an increased budget for the LEAP by $4.5 billion. The increased budget goes toward the Lilly ...
U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center for advanced manufacturing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback